---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-274139"
form_type: "8-K"
ticker: "IMA"
cik: "0001835579"
company_name: "ImageneBio, Inc."
filed_at: "2026-06-17T20:05:45+00:00"
generated_at: "2026-06-17T20:16:26.518251+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Stockholders approve amendment to 2025 Equity Incentive Plan, adding 850,000 shares

## Summary
- Amendment increases authorized shares by 850,000; includes convertible preferred and pre-funded warrants in annual auto-increase calculation.
- Holders elect David P. Bonita, M.D. and Joseph P. Slattery as Class II directors for term until 2029.
- Ratification of PricewaterhouseCoopers LLP as independent auditor for fiscal year 2026.
- All proposals approved with over 84% of votes cast in favor for each (excluding broker non-votes).

## SEC filing metadata
- accession: 0001193125-26-274139
- form_type: 8-K
- ticker: IMA
- cik: 0001835579
- company_name: ImageneBio, Inc.
- filed_at: 2026-06-17T20:05:45+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1835579/000119312526274139/0001193125-26-274139-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1835579/000119312526274139/d114862d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-274139
- JSON: https://secwatch.observer/filing/0001193125-26-274139.json
- Plain text: https://secwatch.observer/filing/0001193125-26-274139.txt

## Key facts
- Shareholder Votes
  ImageneBio, Inc. shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2026-06-16 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2026-06-16
  source text: Proposal 2: Ratification of Appointment of Independent Registered Public Accounting Firm The Company’s stockholders ratified the appointment by the Audit Committee of the Company’s Board of Directors of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. The final voting results are as follows: For Against Abstain 7,613,075 20,477 5
  evidence_url: https://www.sec.gov/Archives/edgar/data/1835579/000119312526274139/0001193125-26-274139-index.htm
- Shareholder Votes
  ImageneBio, Inc. shareholders approved Election of Directors at the 2026-06-16 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2026-06-16
  source text: Proposal 1: Election of Directors The Company’s stockholders elected the following two individuals to serve as Class II directors, to hold office until the 2029 Annual Meeting of Stockholders and their successors are duly elected and qualified or until his earlier death, resignation or removal. The final voting results are as follows: For Withheld Broker Non-Votes David P. Bonita, M.D. 6,980,671 40,117 612,769 Joseph P. Slattery 6,985,414 35,374 612,769
  evidence_url: https://www.sec.gov/Archives/edgar/data/1835579/000119312526274139/0001193125-26-274139-index.htm
- Shareholder Votes
  ImageneBio, Inc. shareholders approved 2025 Amended Plan at the 2026-06-16 meeting.
  - Proposal: equity plan
  - Outcome: passed
  - Meeting: 2026-06-16
  source text: Proposal 3: 2025 Amended Plan The Company’s stockholders approved the Amended Plan. The final voting results are as follows: For Against Abstain Broker Non-Votes 6,322,909 591,191 106,688 612,769
  evidence_url: https://www.sec.gov/Archives/edgar/data/1835579/000119312526274139/0001193125-26-274139-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.